Fresenius Medical Care AG
FME: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€94.00 | Hwvlxv | Rsvw |
Fresenius Medical Care Earnings: Progress Continues as External Pressures Ease
Narrow-moat Fresenius Medical Care turned in decent second-quarter results and increased its guidance for the full year. After tinkering with some of our near-term assumptions, we are keeping our EUR 67 per share fair value estimate unchanged and boosting the ADR fair value to $37 per share on foreign exchange rate changes since our last valuation update.